EB-1A Case Study: Colombian Cancer Genetics Physician Secures USCIS Approval in 14 Days with No RFE 

Colombia

Cancer Physician

For many patients facing a cancer diagnosis, genetic analysis plays a central role in evaluating inherited risk and guiding treatment decisions for both patients and their families. In those moments, accuracy matters, because the results directly inform clinical recommendations and long-term decisions that extend beyond a single individual. 

Our client, a Colombian physician scientist with more than 16 years of experience has spent his career ensuring that genetic test results used in oncology settings met clinical reliability standards.  

Colombo and Hurd Senior Attorney Nicolas Vargas prepared this EB-1A extraordinary ability petition and received United States Citizenship and Immigration Services (USCIS) approval through premium processing in 14 days without a Request for Evidence (RFE).  

EB-1A Approval for Cancer Genetics Physician
Client Profile

A Physician Scientist Advancing Cancer Genetics Through Clinical Leadership

Long before precision oncology became a widely used term, our client was already working in the fields of genetics and patient care. Trained as a physician and geneticist in Colombia, he entered the field at a time when hereditary cancer testing was still limited in much of Latin America and often inaccessible to patients who needed it most.  

With formal education in oncology and medical genetics, he built and led genetic testing programs embedded within clinical and laboratory settings, where accuracy and interpretation directly influenced patient care. As his career progressed, he assumed roles directing genetic testing services and oncology focused laboratories, where he oversaw results in interpretation protocols and the clinical integration of genetic findings in real oncology care settings.  

Over time, his work consistently connected laboratory science and clinical practice, ensuring that genetic data did not remain confined to research papers but instead informed patient care. This sustained record of impact formed the foundation of his EB-1A extraordinary ability petition and positioned him to continue advancing oncology care in the United States. 

The Challenge

Supporting Seven EB-1A Criteria with International Evidence

One of the primary challenges in this EB-1A case was building a petition that fully reflected the depth of the client’s accomplishments without diluting their impact. Given the strength and breadth of the client’s record, our legal team presented seven EB-1A criteria.  

As Attorney Vargas explained, “The challenge was making sure that those seven arguments were all very solid, that there was sufficient context for the officer to fully appreciate our client’s impact.” Another layer of complexity involved presenting achievements earned outside the United States with clear institutional and professional context, so the significance of those achievements was readily understandable. Many of our clients’ awards and credentials originated in Latin America and required explanation to ensure their significance was not overlooked.  

The Strategy

A Structured EB-1A Petition Strategy Designed for Evidentiary Clarity

The strategy was to make the EB-1A petition comprehendible, even when much of the evidence came from Latin America. First, our legal team treated each of the seven criteria as its own standalone argument, establishing a link between the client’s accomplishment and supportingdocuments. Next, the filing added targeted context for awards and credentials earned outside the United States to ensure the record fully reflected their scope and significance. Attorney Vargas emphasized, “Our goal was to present each criterion with enough context that the evidence clearly demonstrated eligibility across all requirements.  

The Result

EB-1A Approval in 14 Days Through Premium Processing with No RFE

The EB-1A petition was approved through premium processing in 14 days without an RFE. By addressing all seven EB-1A criteria with well-documented support, the filing allowed USCIS to complete the review without follow up questions or additional documentation requests. This reduced processing time allowed our client to move forward with plans to continue his oncology, and medical genetics work in the United States. When a client’s achievements span multiple countries and healthcare systems, an approval like this reinforces the value of case preparation in extraordinary ability petitions.  

Why This Case Succeeded

Our Team Succeeded in Providing Evidence of Sustained Impact and Extraordinary Ability

This case succeeded first and foremost because the client’s record fit what USCIS looks for in an EB-1A petition, sustained national or international recognition paired with evidence of high impact work in a critical field. Our legal team also highlighted concrete indicators of distinction that USCIS officers are trained to evaluate, including: 

  • nationally recognized awards 
  • extensive peer reviewed authorship with strong citation history 
  • repeated selection to judge the work of other genetics professionals, and  
  • memberships in leading genetics and oncology associations.  

Independent letters from respected experts further reinforced that his contributions were original and influential in real world oncology practice. Finally, the petition met seven EB-1A criteria organized with enough context for international achievements that the officer could complete review quickly.  

What the Approval Enables

With his EB-1A approval, the client has a clear path toward permanent residency and the ability to continue his work in cancer genetics in the United States without being tied to a single employer or a narrow job description. That flexibility matters in a field where progress often depends on collaboration across hospitals and research teams. 

Additionally, it allows our client to pursue his planned work in precision oncology, including developing tools that help clinicians interpret complex genetic information and apply it in patient care. With the immigration foundation secured, he can focus on building partnerships and contributing to innovation in cancer diagnostics and treatment decision support in the United States. 

Case Overview
Category  Details 
Visa Classification  EB-1A Extraordinary Ability 
Nationality  Colombian 
Professional Field  Oncology and medical genetics 
Education  Doctor of Philosophy (PhD) in Human Genetics, a Master’s Degree in Human Genetics, a Master’s Degree in Business Administration, and a Medical Degree (MD) in Medical Surgeon 
Request for Evidence (RFE)  No 
Final Outcome  EB-1A petition approved by USCIS 
Timeline  14 days through premium processing 
Lead Attorneys  Nicolas Vargas, Senior Immigration Attorney, Colombo and Hurd 
Attorney Perspective

Nicolas Vargas

Senior Attorney

This case reflects what the EB-1A category is meant to recognize. Extraordinary ability is not a single title or one publication. It is about sustained impact over time. Here, we were able to show a long record of leadership in cancer genetics, backed by independent recognition and real clinical influence. When that level of evidence is presented clearly, it allows USCIS to focus on the substance of the work rather than question whether the standard has been met.

Related Resources 

What To Expect In EB-1A Processing Times In 2026   

EB-1A Complete Guide: Requirements, Process, & Timeline 

EB-1A Visa for Colombians: 2026 Guide to U.S. Permanent Residence 

This case was handled by Senior Attorney Nicolas Vargas of Colombo & Hurd, a U.S. immigration law firm focused on extraordinary ability and national interest cases. The firm has secured over 10,000 successful visa and green card approvals for clients from more than 100 countries, including 2,500+ EB-2 NIW and EB-1A approvals since 2023.